Skip to main content

Aptus Capital Advisors, LLC

Position in TMO — Thermo Fisher Scientific Inc.

CIK 1664193 FAIRHOPE, AL

Position in TMO

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$23,609,543
+$881,197 QoQ
Shares Held
47,091
+1.8% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
#438
of 2,606 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 96% Shared 0% None 4%

Common Shares in TMO Over Time

Shares Held

Position Value (USD)

Derivatives in TMO

reported options exposure · as of Sep 30, 2025
CallValue
$291,012,000
CallShares
600,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

Aptus Capital Advisors, LLC holds $37,453,222 across 9 Diagnostics & Research names. TMO ranks #1 (63.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TMO
Thermo Fisher Scientific Inc.
This page
47,091 $23,609,543

All Filings in TMO

Export CSV
28 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $23,609,543 47,091
2026-03-31 $22,728,346 46,240
2025-12-31 $33,575,650 57,944
2025-09-30 $27,251,818 56,187
2025-09-30 $291,012,000 600,000
2025-06-30 $4,744,692 11,702
2025-06-30 $324,368,000 800,000
2025-03-31 $4,314,689 8,671
2024-12-31 $22,359,485 42,980
2024-09-30 $23,360,295 37,765
2024-06-30 $17,568,257 31,769
2024-03-31 $14,573,258 25,074
2023-12-31 $11,925,258 22,467
2023-09-30 $11,354,911 22,433
2023-06-30 $12,219,906 23,421
2023-03-31 $14,210,402 24,655
2022-12-31 $12,636,132 22,946
2022-09-30 $12,442,891 24,533
2022-06-30 $12,446,001 22,909
2022-03-31 $13,540,650 22,925
2021-12-31 $13,272,737 19,892
2021-09-30 $9,645,764 16,883
2021-06-30 $6,474,367 12,834
2021-03-31 $3,065,504 6,717
2020-12-31 $3,056,448 6,562
2020-09-30 $2,478,693 5,614
2020-06-30 $2,016,784 5,566
2020-03-31 $1,830,354 6,454